Yes, academic-done pre-clinical studies are comparatively cheap, so perhaps RAC could commission lots more….
Also perhaps RAC could spend a few dollars on a campaign to inform FTO researchers interested in using a powerful FTO inhibitor that Zantrene exists …then those academic researchers could do valuable, relevant pre-clinical work for free!
So far, three academic groups have used Zantrene as an FTO inhibitor…imagine if hundreds of FTO researchers used Zantrene! imagine all those pre-clinical studies generating positive results for Zantrene, and all done for free!
Perhaps we should all have a little sympathy for Zantrene's pain: Zantrene knows it can help those stupid humans so much, but the humans are so slow and floppy!
Ann: Quarterly Activity Report & Appendix 4C, page-14
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.180(11.5%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.80 | $1.58 | $772.4K | 450.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2354 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 525 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.180 ( 11.2 %) |
||||
| Open | High | Low | Volume | ||
| $1.60 | $1.80 | $1.58 | 22024 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| RAC (ASX) Chart |